Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Acelrx Pharmaceutica (NQ: ACRX )

1.180 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 17, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,264
Open 1.180
Bid (Size) 1.170 (23)
Ask (Size) 1.180 (15)
Prev. Close 1.180
Today's Range 1.180 - 1.180
52wk Range 1.010 - 2.940
Shares Outstanding 119,102,999
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
AcelRx Pharmaceuticals Reports First Quarter 2021 Financial Results
$67.3 million of cash and short-term investments at March 31, 2021 
From PR Newswire
Study of DSUVIA® Showing Significant Reduction in Postoperative Opioids and Better OBAS Scores Compared to Control Group to be Presented at the American Society of Regional Anesthesia (ASRA) Annual Me
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in a medically supervised... 
From PR Newswire

Performance

YTD
-5.60%
-5.60%
1 Month
-1.67%
-1.67%
3 Month
-48.70%
-48.70%
6 Month
-21.85%
-21.85%
1 Year
-17.48%
-17.48%

More News

Read More
AcelRx to Host First Quarter 2021 Financial Results Call and Webcast on May 17, 2021
From PR Newswire
AcelRx Announces an Investigator-Initiated Study of DSUVIA® for Use in Same-Day Total Joint Replacement
From PR Newswire
AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Patients Taking Buprenorphine Who Require a Surgical Procedure
From PR Newswire
AcelRx Pharmaceuticals Announces Appointment of Marina Bozilenko to the Board of Directors
From PR Newswire
AcelRx Pharmaceuticals: Q1 Earnings Insights
Tags Earnings BZI/Recaps Benzinga
From Benzinga
AcelRx's Dsuvia Shows Reduction In Postoperative Opioids Compared To Control Group
Tags ACRX Market News Opioids
From Benzinga
The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off
Tags Pharma/Biotech Stocks / Equities Market News
From Blogs - TalkMarkets
Thinking about buying stock in Atossa Therapeutics, AMC Entertainment, T2 Biosystems, AcelRx Pharmaceuticals, or ENDRA Life Sciences?
From PR Newswire
First Week of December 17th Options Trading For AcelRx Pharmaceuticals (ACRX)
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.